Advancing the global public health agenda for NAFLD: a consensus statement
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …
approximately one-quarter of the global adult population, causing a substantial burden of ill …
[HTML][HTML] Changing epidemiology, global trends and implications for outcomes of NAFLD
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …
disease globally and is currently estimated to affect 38% of the global population. Only a …
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
One quarter of the global population is estimated to have nonalcoholic fatty liver disease
(NAFLD). The incidence of nonalcoholic steatohepatitis (NASH) is projected to increase by …
(NAFLD). The incidence of nonalcoholic steatohepatitis (NASH) is projected to increase by …
[HTML][HTML] MAFLD: How is it different from NAFLD?
C Gofton, Y Upendran, MH Zheng… - Clinical and molecular …, 2023 - ncbi.nlm.nih.gov
Abstract “Metabolic dysfunction-associated fatty liver disease (MAFLD)” is the term
suggested in 2020 to refer to fatty liver disease related to systemic metabolic dysregulation …
suggested in 2020 to refer to fatty liver disease related to systemic metabolic dysregulation …
Hepatocellular carcinoma surveillance—Utilization, barriers and the impact of changing aetiology
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States
Background & Aims The profile of chronic liver disease (CLD) in the United States has
changed due to obesity trends and advances in treatment of viral hepatitis. We assessed …
changed due to obesity trends and advances in treatment of viral hepatitis. We assessed …
[HTML][HTML] Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic …
DJH Tan, CH Ng, SY Lin, XH Pan, P Tay… - The Lancet …, 2022 - thelancet.com
Background The clinical presentation and outcomes of non-alcoholic fatty liver disease
(NAFLD)-related hepatocellular carcinoma are unclear when compared with hepatocellular …
(NAFLD)-related hepatocellular carcinoma are unclear when compared with hepatocellular …
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
What's in a name? Renaming 'NAFLD'to 'MAFLD'
In medicine, language matters and the words used to name and describe a disease can
have a profound impact on patients and their families. Over the last two decades, many …
have a profound impact on patients and their families. Over the last two decades, many …
Redefining fatty liver disease: an international patient perspective
Despite its increased recognition as a major health threat, fatty liver disease associated with
metabolic dysfunction remains largely underdiagnosed and undertreated. An international …
metabolic dysfunction remains largely underdiagnosed and undertreated. An international …